Evidence map›Paper›PMID 27447611›Full record

ArticleInternational journal of molecular sciences2016

Argon Induces Protective Effects in Cardiomyocytes during the Second Window of Preconditioning.

Britta Mayer, Josefin Soppert, Sandra Kraemer, Sabrina Schemmel, Christian Beckers, Christian Bleilevens, Rolf Rossaint, Mark Coburn, Andreas Goetzenich, Christian Stoppe

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Britta MayerDepartment of Thoracic & Cardiovascular Surgery, University Hospital RWTH, 52074 Aachen, Germany. Britta.Mayer@rwth-aachen.de.
Josefin SoppertDepartment of Thoracic & Cardiovascular Surgery, University Hospital RWTH, 52074 Aachen, Germany. jsoppert@ukaachen.de.
Sandra KraemerDepartment of Thoracic & Cardiovascular Surgery, University Hospital RWTH, 52074 Aachen, Germany. skraemer@ukaachen.de.
Sabrina SchemmelDepartment of Thoracic & Cardiovascular Surgery, University Hospital RWTH, 52074 Aachen, Germany. Sabrina.Schemmel@rwth-aachen.de.
Christian BeckersDepartment of Thoracic & Cardiovascular Surgery, University Hospital RWTH, 52074 Aachen, Germany. cbeckers@ukaachen.de.
Christian BleilevensDepartment of Anesthesiology, University Hospital RWTH, 52074 Aachen, Germany. cbleilevens@ukaachen.de.
Rolf RossaintDepartment of Anesthesiology, University Hospital RWTH, 52074 Aachen, Germany. rrossaint@ukaachen.de.
Mark CoburnDepartment of Anesthesiology, University Hospital RWTH, 52074 Aachen, Germany. mcoburn@ukaachen.de.
Andreas GoetzenichDepartment of Thoracic & Cardiovascular Surgery, University Hospital RWTH, 52074 Aachen, Germany. agoetzenich@ukaachen.de.
Christian StoppeDepartment of Anesthesiology, University Hospital RWTH, 52074 Aachen, Germany. christian.stoppe@gmail.com.
RWTH Aachen University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Increasing evidence indicates that argon has organoprotective properties. So far, the underlying mechanisms remain poorly understood. Therefore, we investigated the effect of argon preconditioning in cardiomyocytes within the first and second window of preconditioning. Primary isolated cardiomyocytes from neonatal rats were subjected to 50% argon for 1 h, and subsequently exposed to a sublethal dosage of hypoxia (<1% O₂) for 5 h either within the first (0-3 h) or second window (24-48 h) of preconditioning. Subsequently, the cell viability and proliferation was measured. The argon-induced effects were assessed by evaluation of mRNA and protein expression after preconditioning. Argon preconditioning did not show any cardioprotective effects in the early window of preconditioning, whereas it leads to a significant increase of cell viability 24 h after preconditioning compared to untreated cells (p = 0.015) independent of proliferation. Argon-preconditioning significantly increased the mRNA expression of heat shock protein (HSP) B1 (HSP27) (p = 0.048), superoxide dismutase 2 (SOD2) (p = 0.001), vascular endothelial growth factor (VEGF) (p < 0.001) and inducible nitric oxide synthase (iNOS) (p = 0.001). No difference was found with respect to activation of pro-survival kinases in the early and late window of preconditioning. The findings provide the first evidence of argon-induced effects on the survival of cardiomyocytes during the second window of preconditioning, which may be mediated through the induction of HSP27, SOD2, VEGF and iNOS.

Indexed as

Ischemic Preconditioning, MyocardialAnimalsArgonBlotting, WesternCell ProliferationCell SurvivalCytoprotectionHeart DiseasesHeat-Shock ProteinsMyocytes, CardiacNitric Oxide Synthase Type IIRatsRats, WistarReal-Time Polymerase Chain ReactionSuperoxide DismutaseSuperoxide Dismutase 2ArgonHeat-Shock ProteinsNitric Oxide Synthase Type IISuperoxide DismutaseSuperoxide Dismutase 2Vascular Endothelial Growth Factor Aargoncardiomyocytescardioprotectionlate phase of preconditioning

Identifiers

PMID27447611
PMCPMC4964531
OpenAlexW2480151737

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.